TGRX-678 Phase I Oral Pharmacokinetic Study

Clinical trial NCT06697899 · COMPLETED

Trial details

NCT number: NCT06697899
Sponsor: Shenzhen TargetRx Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2024-11-24
Primary completion: 2025-01-06
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.